基于胃肠道GLP-1R靶点的Exendin-4显像用于IBD诊断与疗效评估
本研究用DSS诱导的IBD大鼠(n=6)行[68Ga]Ga-NOTA-MAL-Cys39-exendin-4 micro-PET/CT,发现正常大鼠GLP-1R集中于近端十二指肠,DSS诱导后近端十二指肠摄取较对照显著升高,结肠摄取升高与上皮损伤组织病理评分密切相关;利拉鲁肽治疗后近端十二指肠摄取降低。
要点
- 正常大鼠GLP-1R高浓集于近端十二指肠,结肠段远端附近分布密度较高。
- DSS诱导后近端十二指肠对[68Ga]Ga-NOTA-MAL-Cys39-exendin-4摄取较对照显著升高。
- 结肠摄取升高与上皮损伤组织病理评分密切相关,利拉鲁肽治疗后近端十二指肠摄取降低。
核心结论
- 分子显像可用于评估GLP-1R表达的动态变化,并可能改善IBD等胃肠道疾病的诊断与治疗策略。
- 支持以Brunner腺作为观察GLP-1R表达的关键部位,推进GLP-1R/GLP-1RA轴在复杂胃肠道疾病中的研究。
研究设计与样本
- 使用DSS诱导的IBD大鼠(n=6),以定量micro-PET/CT测定DSS诱导前后胃肠道GLP-1R表达变化。
- 在IBD大鼠中评估利拉鲁肽治疗后GLP-1R表达的动态变化,并检测十二指肠和结肠组织中GLP-1R与炎症因子的转录水平进行相关性分析。
主要发现
- 正常大鼠GLP-1R高度集中于近端十二指肠,在结肠段远端附近分布密度较高。
- DSS诱导后近端十二指肠对[68Ga]Ga-NOTA-MAL-Cys39-exendin-4的摄取较对照显著升高。
- 结肠摄取升高与上皮损伤的组织病理评分密切相关。
- 利拉鲁肽治疗的IBD大鼠近端十二指肠摄取降低。
- Western blotting和定量PCR证实疾病进展过程中GLP-1R表达发生变化。
临床怎么用
- 原文结论指出分子显像有助于评估GLP-1R表达动态变化并可能改善IBD等胃肠道疾病的诊疗策略,支持以Brunner腺作为观察GLP-1R表达的关键部位。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Diagnosis of inflammatory bowel disease (IBD) involves history-taking and invasive procedures that primarily evaluate localized intestinal structures. Notably, glucagon-like peptide 1 (GLP-1) and its receptor (GLP-1R) have been established as potent participants in various inflammatory diseases. This study aimed to investigate the potential of molecular imaging targeting GLP-1R in the study of gastrointestinal physiology and disease. METHODS: Using dextran sulfate sodium (DSS)-induced IBD rats (n = 6), changes in GLP-1R expression in the gastrointestinal tract before and after DSS induction were determined by quantitative micro-PET/CT. Dynamic changes in GLP-1R expression after liraglutide treatment were also assessed in IBD rats. Transcription of GLP-1R and inflammatory factors in duodenal and colonic tissues were measured and subjected to correlation analysis. RESULTS: In normal rats, GLP-1R was highly concentrated in the proximal duodenum, with a higher distribution density near the distal end of the colonic segment. Proximal duodenal uptake of [68Ga]Ga-NOTA-MAL-Cys39-exendin-4 was significantly increased after DSS induction compared with controls. The increased colonic uptake closely correlated with the histopathologic score of epithelial injury. In IBD rats treated with liraglutide, proximal duodenal uptake was reduced. In addition, Western blotting and quantitative PCR confirmed changes in GLP-1R expression during disease progression. CONCLUSION: These findings underscore the role of molecular imaging in assessing dynamic changes in GLP-1R expression and its potential for improving diagnostic and therapeutic strategies for gastrointestinal disorders like IBD. It supports using Brunner's glands as a key site to observe GLP-1R expression, advancing research on the GLP-1R/GLP-1RA axis in complex gastrointestinal conditions.
引用
- Li X, Liu Y, Zhang Z, et al. Exendin-4 imaging based on gastrointestinal GLP-1R targets for IBD diagnosis and efficacy assessment. Eur J Nucl Med Mol Imaging. 2025. PMID: 40178570. doi:10.1007/s00259-025-07197-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。